Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | CTSB | P07858 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.33 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | MGLL | Q99685 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16695057 | 0.93 | KMT2A (0.35) | KMT2ATSHRHSD17B10CTSBLMNA | |
| SCHEMBL27770082 | 0.82 | KMT2A (0.40) | KMT2ATSHRHSD17B10CTSBLMNA | |
| SCHEMBL28859669 | 0.80 | KMT2A (0.31) | KMT2A | |
| SCHEMBL27923799 | 0.80 | OPRM1 (0.37) | CYP2D6 | |
| SCHEMBL1314189 | 0.80 | ROCK2 (0.33) | HSD17B10ALDH1A1GAA | |
| SCHEMBL3680128 | 0.78 | KMT2A (0.39) | KMT2ATSHRHSD17B10CTSBLMNA | |
| SCHEMBL3674763 | 0.78 | KMT2A (0.39) | KMT2ATSHRHSD17B10CTSBLMNA | |
| SCHEMBL3684937 | 0.78 | KMT2A (0.39) | KMT2ATSHRHSD17B10CTSBLMNA | |
| SCHEMBL3680130 | 0.78 | KMT2A (0.39) | KMT2ATSHRHSD17B10CTSBLMNA | |
| SCHEMBL1315359 | 0.78 | ROCK2 (0.35) | KMT2ATSHRHSD17B10LMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2871199-B1 | METHOD FOR PRODUCING AROMATIC COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2018-02-21 | — | — | EP | disclosed |
| EP-2871199-B1 | METHOD FOR PRODUCING AROMATIC COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2018-02-21 | — | — | EP | disclosed |
| US-9238665-B2 | Method for producing aromatic compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-01-19 | — | — | US | disclosed |
| US-9238665-B2 | Method for producing aromatic compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-01-19 | — | — | US | disclosed |
| US-9238665-B2 | Method for producing aromatic compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-01-19 | — | — | US | disclosed |
| US-20150322101-A1 | METHOD FOR PRODUCING AROMATIC COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-11-12 | — | — | US | disclosed |
| US-20150322101-A1 | METHOD FOR PRODUCING AROMATIC COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-11-12 | — | — | US | disclosed |
| US-20150322101-A1 | METHOD FOR PRODUCING AROMATIC COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-11-12 | — | — | US | disclosed |
| EP-2871199-A1 | METHOD FOR PRODUCING AROMATIC COMPOUND | Sumitomo Chemical Company Limited (JP) | 2015-05-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150322101-A1 | METHOD FOR PRODUCING AROMATIC COMPOUND | PAH, DDC, PHOSPHO1 | KMT2A 1662/4885TSHR 3484/4885HSD17B10 3128/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.